Stocktoria
REVVITY, INC. RVTY
NYSE · XNYS · stock · Laboratory Analytical Instruments · website · IPO 1965-07-06
REVVITY, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $2.9B | $2.8B | $2.8B | $3.3B | $3.8B |
| Gross profit | — | — | — | $2.0B | $2.4B |
| R&D expense | $215.8M | $196.8M | $216.6M | $221.6M | $200.3M |
| SG&A expense | $991.9M | $994.1M | $1.0B | $1.0B | $975.2M |
| Operating income | $356.6M | $346.7M | $300.6M | $742.7M | $1.3B |
| Income tax | $28.4M | $33.1M | $3.5M | $139.2M | $314.1M |
| Net income | $241.2M | $270.4M | $693.1M | $569.2M | $943.2M |
| EPS (diluted) | $2.07 | $2.20 | $5.55 | $4.50 | $8.08 |
| Operating cash flow | $589.0M | $665.0M | $279.4M | $679.8M | $1.4B |
| Free cash flow | $515.4M | $578.3M | $198.0M | $594.2M | $1.3B |
| Cash & equivalents | $919.9M | $1.2B | $913.2M | $454.4M | $603.3M |
| Inventory | $379.5M | $367.6M | $428.1M | $405.5M | $425.9M |
| Total assets | $12.2B | $12.4B | $13.6B | $14.1B | $15.0B |
| Total liabilities | $4.9B | $4.7B | $5.7B | $6.7B | $7.9B |
| Shareholders' equity | $7.3B | $7.7B | $7.9B | $7.4B | $7.1B |
Source: SEC EDGAR filings · CIK 0000031791 · as of 2025-12-28. Facts from filings plus Stocktoria's own computed scores — not investment advice.